Blood exosomes from 18 pancreatic cancer patients and 16 healthy controls were collected for detection of miR-21, miR-191, and miR-451a by molecular beacon–peptide (MBP) probes, showing increased expression of these miRNAs in pancreatic cancer patients [36]. This evidence concerns the gene MBP and familial pancreatic carcinoma.